Dr. Sushil Giri

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (7)

• Multi-Target Antioxidant Potential of Tricin Against Parkinson’s Disease-Linked Oxidative Stress
  Sushil Giri, Phool Chandra
  Current Protein & Peptide Science 2026 DOI: 10.2174/0113892037405800251209190725
  +Save
• Neuroprotective and safety evaluation of tricin in an MPTP-induced rat model of Parkinson’s disease
  Next Research 2026 DOI: 10.1016/j.nexres.2026.101818
  +Save
• Modulation of neuropathological pathways by bioactive peptides and proteins/polypeptides: Targeting oxidative stress in neurodegenerative diseases
  Neuropeptides 2025 DOI: 10.1016/j.npep.2025.102563
  +Save
• Therapeutic Potential of Natural Flavonoids: Pharmacological Targets, Signaling Pathways, Molecular Mechanisms, and Clinical Perspective on Parkinson's Disease
  Sushil Giri, Phool Chandra
  Current Drug Therapy 2025 DOI: 10.2174/0115748855292178240223100534
  +Save
• Therapeutic Potential and Prospects of L-arginine in Various Diseases and its Clinical Intervention
  Sushil Giri, Krishna Kumar Varshney, Rajnish Srivastava
  Current Drug Therapy 2024 DOI: 10.2174/0115748855260802231019072509
  +Save
• TARGETING TAU HYPERPHOSPHORYLATION IN ALZHEIMER’S DISEASE: EXPLORING NOVEL DYRK1A AND CLK1 KINASE INHIBITORS VIA STRUCTURE-BASED VIRTUAL SCREENING
  Dr. G. Suchitra, Sajeeda Niketh, Tanmay Ghosh

  +6 more

  • Anil C. Venkata Kumar
  • T. P. Rao
  • Vishal Pathak
  • Sushil Giri
  • Rajashekar Perusomula
  • +1 more
  BIOCHEMICAL AND CELLULAR ARCHIVES 2024 DOI: 10.51470/bca.2024.24.1.645
  +Save
• Coenzyme Q10: A potential breakthrough in physiological dysfunctions
  INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH 2020 DOI: 10.13040/ijpsr.0975-8232.11(2).599-04
  +Save